The DOI matches its Crossref record; 148 of the 148 references it cites were found in a registry or an index.
The Wnt signaling pathway in cancer
Open accessAbstract
The Wnt signaling pathway is critically involved in both the development and homeostasis of tissues via regulation of their endogenous stem cells. Aberrant Wnt signaling has been described as a key player in the initiation of and/or maintenance and development of many cancers, via affecting the behavior of Cancer Stem Cells (CSCs). CSCs are considered by most to be responsible for establishment of the tumor and also for disease relapse, as they possess inherent drug-resistance properties. The development of new therapeutic compounds targeting the Wnt signaling pathway promises new hope to eliminate CSCs and achieve cancer eradication. However, a major challenge resides in developing a strategy efficient enough to target the dysregulated Wnt pathway in CSCs, while being safe enough to not damage the normal somatic stem cell population required for tissue homeostasis and repair. Here we review recent therapeutic approaches to target the Wnt pathway and their clinical applications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Epigenetic regulation of Wnt-signaling pathway in acute lymphoblastic leukemia
Román-Gómez, J., Cordeu, L., Agirre, X., Jiménez-Velasco, A., San José-Eneriz, E., Garate, L., Calasanz, M. J., Heiniger, A., Torres, A., & Prosper, F. (2007) · Blood · doi:10.1182/blood-2006-09-047043 · Cited by 168
RetractedProspective identification of tumorigenic breast cancer cells
Al-Hajj, M., Wicha, M. S., Benito-Hernandez, A., Morrison, S. J., & Clarke, M. F. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0530291100 · Cited by 10,370
Stem cells, cancer, and cancer stem cells
Reya, T., Morrison, S. J., Clarke, M. F., & Weissman, I. L. (2001) · Nature · doi:10.1038/35102167 · Cited by 9,738
Identification of human brain tumour initiating cells
Singh, S. K., Hawkins, C., Clarke, I. D., Squire, J. A., Bayani, J., Hide, T., Henkelman, R. M., Cusimano, M. D., & Dirks, P. B. (2004) · Nature · doi:10.1038/nature03128 · Cited by 7,433
A cell initiating human acute myeloid leukaemia after transplantation into SCID mice
Lapidot, T., Sirard, C., Vormoor, J., Murdoch, B., Hoang, T., Caceres-Cortes, J., Minden, M., Paterson, B., Caligiuri, M. A., & Dick, J. E. (1994) · Nature · doi:10.1038/367645a0 · Cited by 4,783
A human colon cancer cell capable of initiating tumour growth in immunodeficient mice
O’Brien, C. A., Pollett, A., Gallinger, S., & Dick, J. E. (2007) · Nature · doi:10.1038/nature05372 · Cited by 4,087
Identification of Pancreatic Cancer Stem Cells
Li, C., Heidt, D. G., Dalerba, P., Burant, C. F., Zhang, L., Adsay, V., Wicha, M., Clarke, M. F., & Simeone, D. M. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2030 · Cited by 3,339
The Effect of Celecoxib, a Cyclooxygenase-2 Inhibitor, in Familial Adenomatous Polyposis
Steinbach, G., Lynch, P. M., Phillips, R. K. S., Wallace, M. H., Hawk, E., Gordon, G. B., Wakabayashi, N., Saunders, B., Shen, Y., Fujimura, T., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200006293422603 · Cited by 2,526
The bone marrow niche for haematopoietic stem cells
Morrison, S. J., & Scadden, D. T. (2014) · Nature · doi:10.1038/nature12984 · Cited by 2,451
A restricted cell population propagates glioblastoma growth after chemotherapy
Chen, J., Li, Y., Yu, T.-S., McKay, R. M., Burns, D. K., Kernie, S. G., & Parada, L. F. (2012) · Nature · doi:10.1038/nature11287 · Cited by 2,354
Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling
Huang, S.-M. A., Mishina, Y. M., Liu, S., Cheung, A., Stegmeier, F., Michaud, G. A., Charlat, O., Wiellette, E., Zhang, Y., Wiessner, S., et al. (2009) · Nature · doi:10.1038/nature08356 · Cited by 2,037
The cancer stem cell: premises, promises and challenges
Clevers, H. (2011) · Nature Medicine · doi:10.1038/nm.2304 · Cited by 1,923
Nusse, R., & Varmus, H. E. (1982) · Cell · doi:10.1016/0092-8674(82)90409-3 · Cited by 1,863
Wnt activity defines colon cancer stem cells and is regulated by the microenvironment
Vermeulen, L., De Sousa E Melo, F., van der Heijden, M., Cameron, K., de Jong, J. H., Borovski, T., Tuynman, J. B., Todaro, M., Merz, C., Rodermond, H., et al. (2010) · Nature Cell Biology · doi:10.1038/ncb2048 · Cited by 1,804
WNT and β-catenin signalling: diseases and therapies
Moon, R. T., Kohn, A. D., Ferrari, G. V. D., & Kaykas, A. (2004) · Nature Reviews Genetics · doi:10.1038/nrg1427 · Cited by 1,763
Wnt signalling and its impact on development and cancer
Klaus, A., & Birchmeier, W. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2389 · Cited by 1,595
Transformation from committed progenitor to leukaemia stem cell initiated by MLL–AF9
Krivtsov, A. V., Twomey, D., Feng, Z., Stubbs, M. C., Wang, Y., Faber, J., Levine, J. E., Wang, J., Hahn, W. C., Gilliland, D. G., et al. (2006) · Nature · doi:10.1038/nature04980 · Cited by 1,513
The complex world of WNT receptor signalling
Niehrs, C. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3470 · Cited by 1,492
Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML
Jamieson, C. H. M., Ailles, L. E., Dylla, S. J., Muijtjens, M., Jones, C., Zehnder, J. L., Gotlib, J., Li, K., Manz, M. G., Keating, A., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040258 · Cited by 1,485
Thun, M. J., Henley, S. J., & Patrono, C. (2002) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/94.4.252 · Cited by 1,433
A Randomized Trial of Aspirin to Prevent Colorectal Adenomas
Baron, J. A., Cole, B. F., Sandler, R. S., Haile, R. W., Ahnen, D., Bresalier, R., McKeown-Eyssen, G., Summers, R. W., Rothstein, R., Burke, C. A., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021735 · Cited by 1,416
Veeman, M. T., Axelrod, J. D., & Moon, R. T. (2003) · Developmental Cell · doi:10.1016/s1534-5807(03)00266-1 · Cited by 1,359
A tumorigenic subpopulation with stem cell properties in melanomas
Fang, D., Nguyen, T. K., Leishear, K., Finko, R., Kulp, A. N., Hotz, S., Van Belle, P. A., Xu, X., Elder, D. E., & Herlyn, M. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1343 · Cited by 1,280
Identification and Characterization of Tumorigenic Liver Cancer Stem/Progenitor Cells
Ma, S., Chan, K., Hu, L., Lee, T. K., Wo, J. Y., Ng, I. O., Zheng, B., & Guan, X. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.04.025 · Cited by 1,192
Towards an integrated view of Wnt signaling in development
van Amerongen, R., & Nusse, R. (2009) · Development · doi:10.1242/dev.033910 · Cited by 1,175
Sandler, R. S., Halabi, S., Baron, J. A., Budinger, S., Paskett, E., Keresztes, R., Petrelli, N., Pipas, J. M., Karp, D. D., Loprinzi, C. L., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021633 · Cited by 1,136
Lineage Tracing Reveals Lgr5 + Stem Cell Activity in Mouse Intestinal Adenomas
Schepers, A. G., Snippert, H. J., Stange, D. E., van den Born, M., van Es, J. H., van de Wetering, M., & Clevers, H. (2012) · Science · doi:10.1126/science.1224676 · Cited by 1,072
Can we safely target the WNT pathway?
Kahn, M. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4233 · Cited by 1,034
Self-citationEnvironment-mediated drug resistance: A major contributor to minimal residual disease
Meads, M. B., Gatenby, R. A., & Dalton, W. S. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2714 · Cited by 892
Prostaglandin E 2 Promotes Colon Cancer Cell Growth Through a G s -Axin-ß-Catenin Signaling Axis
Castellone, M. D., Teramoto, H., Williams, B. O., Druey, K. M., & Gutkind, J. S. (2005) · Science · doi:10.1126/science.1116221 · Cited by 883
A small molecule inhibitor of β-catenin/cyclic AMP response element-binding protein transcription
Emami, K. H., Nguyen, C., Ma, H., Kim, D. H., Jeong, K. W., Eguchi, M., Moon, R. T., Teo, J.-L., Oh, S. W., Kim, H. Y., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404875101 · Cited by 874
Self-citationPálmer, H. G., González-Sancho, J. M., Espada, J., Berciano, M. T., Puig, I., Baulida, J., Quintanilla, M., Cano, A., de Herreros, A. G., Lafarga, M., et al. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.200102028 · Cited by 802
The Wnt/β-Catenin Pathway Is Required for the Development of Leukemia Stem Cells in AML
Wang, Y., Krivtsov, A. V., Sinha, A. U., North, T. E., Goessling, W., Feng, Z., Zon, L. I., & Armstrong, S. A. (2010) · Science · doi:10.1126/science.1186624 · Cited by 763
Defining the mode of tumour growth by clonal analysis
Driessens, G., Beck, B., Caauwe, A., Simons, B. D., & Blanpain, C. (2012) · Nature · doi:10.1038/nature11344 · Cited by 717
Wnt signaling in the intestinal epithelium: from endoderm to cancer
Gregorieff, A., & Clevers, H. (2005) · Genes & Development · doi:10.1101/gad.1295405 · Cited by 679
Balancing cell adhesion and Wnt signaling, the key role of β-catenin
Brembeck, F. H., Rosário, M., & Birchmeier, W. (2006) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2005.12.007 · Cited by 668
β-Catenin destruction complex: insights and questions from a structural perspective
Kimelman, D., & Xu, W. (2006) · Oncogene · doi:10.1038/sj.onc.1210055 · Cited by 628
Interplay of Cadherin-Mediated Cell Adhesion and Canonical Wnt Signaling
Heuberger, J., & Birchmeier, W. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a002915 · Cited by 619
Gurney, A., Axelrod, F., Bond, C. J., Cain, J., Chartier, C., Donigan, L., Fischer, M., Chaudhari, A., Ji, M., Kapoun, A. M., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1120068109 · Cited by 614
Transcriptional regulation of cell polarity in EMT and cancer
Moreno-Bueno, G., Portillo, F., & Cano, A. (2008) · Oncogene · doi:10.1038/onc.2008.346 · Cited by 610
Wnt signaling: is the party in the nucleus?
Willert, K., & Jones, K. A. (2006) · Genes & Development · doi:10.1101/gad.1424006 · Cited by 589
Gene expression changes associated with progression and response in chronic myeloid leukemia
Radich, J. P., Dai, H., Mao, M., Oehler, V., Schelter, J., Druker, B., Sawyers, C., Shah, N., Stock, W., Willman, C. L., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510423103 · Cited by 583
β-Catenin hits chromatin: regulation of Wnt target gene activation
Mosimann, C., Hausmann, G., & Basler, K. (2009) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2654 · Cited by 575
McMahon, A. P., & Moon, R. T. (1989) · Cell · doi:10.1016/0092-8674(89)90506-0 · Cited by 529
Brabletz, T., Hlubek, F., Spaderna, S., Schmalhofer, O., Hiendlmeyer, E., Jung, A., & Kirchner, T. (2005) · Cells Tissues Organs · doi:10.1159/000084509 · Cited by 528
Fleming, H. E., Janzen, V., Lo Celso, C., Guo, J., Leahy, K. M., Kronenberg, H. M., & Scadden, D. T. (2008) · Cell Stem Cell · doi:10.1016/j.stem.2008.01.003 · Cited by 505
Grösch, S., Tegeder, I., Niederberger, E., Bräutigam, L., & Geisslinger, G. (2001) · The FASEB Journal · doi:10.1096/fj.01-0299fje · Cited by 501
Targeting Hedgehog — a Cancer Stem Cell Pathway
Merchant, A. A., & Matsui, W. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-2846 · Cited by 500
Targeting Wnt Signaling: Can We Safely Eradicate Cancer Stem Cells?
Takahashi-Yanaga, F., & Kahn, M. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-2943 · Cited by 499
Self-citationβ-Catenin Signaling and Roles in Liver Homeostasis, Injury, and Tumorigenesis
Monga, S. P. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.02.056 · Cited by 487
Autoregulation of E-cadherin expression by cadherin–cadherin interactions
Conacci-Sorrell, M., Simcha, I., Ben-Yedidia, T., Blechman, J., Savagner, P., & Ben-Ze'ev, A. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200308162 · Cited by 474
Cancer Stem Cells and Self-renewal
O'Brien, C. A., Kreso, A., & Jamieson, C. H. M. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-2824 · Cited by 472
Kirstetter, P., Anderson, K., Porse, B. T., Jacobsen, S. E. W., & Nerlov, C. (2006) · Nature Immunology · doi:10.1038/ni1381 · Cited by 446
Making sense of hematopoietic stem cell niches
Boulais, P. E., & Frenette, P. S. (2015) · Blood · doi:10.1182/blood-2014-09-570192 · Cited by 442
Phillips, R. K. S., Wallace, M. H., Lynch, P. M., Hawk, E., Gordon, G. B., Saunders, B. P., Wakabayashi, N., Shen, Y., Zimmerman, S., Godio, L., et al. (2002) · Gut · doi:10.1136/gut.50.6.857 · Cited by 441
Baker, N. E. (1987) · The EMBO Journal · doi:10.1002/j.1460-2075.1987.tb02429.x · Cited by 435
Expression of CD44 in Apc and TcfMutant Mice Implies Regulation by the WNT Pathway
Wielenga, V. J. M., Smits, R., Korinek, V., Smit, L., Kielman, M., Fodde, R., Clevers, H., & Pals, S. T. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65297-2 · Cited by 433
DiMeo, T. A., Anderson, K., Phadke, P., Feng, C., Perou, C. M., Naber, S., & Kuperwasser, C. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4135 · Cited by 414
Cancer stem cell markers in common cancers – therapeutic implications
Klonisch, T., Wiechec, E., Hombach-Klonisch, S., Ande, S. R., Wesselborg, S., Schulze-Osthoff, K., & Los, M. (2008) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2008.08.003 · Cited by 393
A Role for the Wnt Gene Family in Hematopoiesis: Expansion of Multilineage Progenitor Cells
Austin, T. W., Solar, G. P., Ziegler, F. C., Liem, L., & Matthews, W. (1997) · Blood · doi:10.1182/blood.v89.10.3624 · Cited by 360
β-Catenin Is Dispensable for Hematopoiesis and Lymphopoiesis
Cobas, M., Wilson, A., Ernst, B., Mancini, S. J. C., MacDonald, H. R., Kemler, R., & Radtke, F. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031615 · Cited by 357
Colorectal Cancer and Nonsteroidal Anti-inflammatory Drugs
Smalley, W. E., & DuBois, R. N. (1997) · Advances in Pharmacology · doi:10.1016/s1054-3589(08)60067-8 · Cited by 356
Kadowaki, T., Wilder, E., Klingensmith, J., Zachary, K., & Perrimon, N. (1996) · Genes & Development · doi:10.1101/gad.10.24.3116 · Cited by 348
Dynamic niches in the origination and differentiation of haematopoietic stem cells
Wang, L. D., & Wagers, A. J. (2011) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3184 · Cited by 343
Wnt addiction of genetically defined cancers reversed by PORCN inhibition
Madan, B., Ke, Z., Harmston, N., Ho, S. Y., Frois, A. O., Alam, J., Jeyaraj, D. A., Pendharkar, V, Ghosh, K., Virshup, I. H., et al. (2016) · Oncogene · doi:10.1038/onc.2015.280 · Cited by 341
Mlodzik, M. (2002) · Trends in Genetics · doi:10.1016/s0168-9525(02)02770-1 · Cited by 341
Role of Members of the Wnt Gene Family in Human Hematopoiesis
Van Den Berg, D. J., Sharma, A. K., Bruno, E., & Hoffman, R. (1998) · Blood · doi:10.1182/blood.v92.9.3189 · Cited by 339
Stem cells in the skin: waste not, Wnt not
Alonso, L., & Fuchs, E. (2003) · Genes & Development · doi:10.1101/gad.1086903 · Cited by 336
Notch Signaling in the Regulation of Stem Cell Self-Renewal and Differentiation
Liu, J., Sato, C., Cerletti, M., & Wagers, A. (2010) · Current Topics in Developmental Biology · doi:10.1016/s0070-2153(10)92012-7 · Cited by 311
Wnt-5A/Ror2 Regulate Expression of XPAPC through an Alternative Noncanonical Signaling Pathway
Schambony, A., & Wedlich, D. (2007) · Developmental Cell · doi:10.1016/j.devcel.2007.02.016 · Cited by 310
Yamamoto, S., Nishimura, O., Misaki, K., Nishita, M., Minami, Y., Yonemura, S., Tarui, H., & Sasaki, H. (2008) · Developmental Cell · doi:10.1016/j.devcel.2008.05.007 · Cited by 305
A canonical to non-canonical Wnt signalling switch in haematopoietic stem-cell ageing
Florian, M. C., Nattamai, K. J., Dörr, K., Marka, G., Überle, B., Vas, V., Eckl, C., Andrä, I., Schiemann, M., Oostendorp, R. A. J., et al. (2013) · Nature · doi:10.1038/nature12631 · Cited by 303
Nakamura, T., Hamada, F., Ishidate, T., Anai, K., Kawahara, K., Toyoshima, K., & Akiyama, T. (1998) · Genes to Cells · doi:10.1046/j.1365-2443.1998.00198.x · Cited by 296
Yamada, T., Takaoka, A., Naishiro, Y., Hayashi, R., Maruyama, K., Maesawa, C., Ochiai, A., & Hirohashi, S. (2000) · PubMed · Cited by 285
Wnt control of stem cells and differentiation in the intestinal epithelium
Pinto, D., & Clevers, H. (2005) · Experimental Cell Research · doi:10.1016/j.yexcr.2005.02.022 · Cited by 279
Manabe, A., Coustan-Smith, E., Behm, F., Raimondi, S., & Campana, D. (1992) · Blood · doi:10.1182/blood.v79.9.2370.2370 · Cited by 275
Zhang, B., Li, M., McDonald, T., Holyoake, T. L., Moon, R. T., Campana, D., Shultz, L., & Bhatia, R. (2013) · Blood · doi:10.1182/blood-2012-02-412890 · Cited by 264
Targeting the Wnt pathway in human cancers: Therapeutic targeting with a focus on OMP-54F28
Le, P. N., McDermott, J. D., & Jimeno, A. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.08.005 · Cited by 253
The Wnt signaling pathway in cellular proliferation and differentiation: A tale of two coactivators
Teo, J.-L., & Kahn, M. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.09.012 · Cited by 248
Self-citationGlycogen synthase kinase 3β missplicing contributes to leukemia stem cell generation
Abrahamsson, A. E., Geron, I., Gotlib, J., Dao, K.-H. T., Barroga, C. F., Newton, I. G., Giles, F. J., Durocher, J., Creusot, R. S., Karimi, M., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0900189106 · Cited by 246
Li, L., Osdal, T., Ho, Y., Chun, S., McDonald, T., Agarwal, P., Lin, A., Chu, S., Qi, J., Li, L., et al. (2014) · Cell stem cell · doi:10.1016/j.stem.2014.08.001 · Cited by 234
Deadly crosstalk: Notch signaling at the intersection of EMT and cancer stem cells
Espinoza, I., & Miele, L. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.08.027 · Cited by 232
Fujii, N., You, L., Xu, Z., Uematsu, K., Shan, J., He, B., Mikami, I., Edmondson, L. R., Neale, G., Zheng, J., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2726 · Cited by 232
Heidel, F. H., Bullinger, L., Feng, Z., Wang, Z., Neff, T. A., Stein, L., Kalaitzidis, D., Lane, S. W., & Armstrong, S. A. (2012) · Cell Stem Cell · doi:10.1016/j.stem.2012.02.017 · Cited by 225
Liu, C.-C., Tsai, C.-W., Deak, F., Rogers, J., Penuliar, M., Sung, Y. M., Maher, J. N., Fu, Y., Li, X., Xu, H., et al. (2014) · Neuron · doi:10.1016/j.neuron.2014.08.048 · Cited by 222
Wnt/beta-Catenin Signaling and Small Molecule Inhibitors
Voronkov, A., & Krauss, S. (2013) · Current Pharmaceutical Design · doi:10.2174/138161213804581837 · Cited by 221
Long-term, multilineage hematopoiesis occurs in the combined absence of β-catenin and γ-catenin
Jeannet, G., Scheller, M., Scarpellino, L., Duboux, S., Gardiol, N., Back, J., Kuttler, F., Malanchi, I., Birchmeier, W., Leutz, A., et al. (2008) · Blood · doi:10.1182/blood-2007-07-102558 · Cited by 215
Identification of a Specific Inhibitor of the Dishevelled PDZ Domain
Shan, J., Shi, D.-L., Wang, J., & Zheng, J. (2005) · Biochemistry · doi:10.1021/bi0512602 · Cited by 213
Moon, R. T. (2005) · Science's STKE · doi:10.1126/stke.2712005cm1 · Cited by 212
NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, EICOSANOIDS, AND COLORECTAL CANCER PREVENTION
DuBois, R. N., Giardiello, F. M., & Smalley, W. E. (1996) · Gastroenterology Clinics of North America · doi:10.1016/s0889-8553(05)70274-0 · Cited by 209
Luis, T. C., Ichii, M., Brugman, M. H., Kincade, P., & Staal, F. J. T. (2012) · Leukemia · doi:10.1038/leu.2011.387 · Cited by 208
Discovery and Characterization of a Small Molecule Inhibitor of the PDZ Domain of Dishevelled
Grandy, D., Shan, J., Zhang, X., Rao, S., Akunuru, S., Li, H., Zhang, Y., Alpatov, I., Zhang, X. A., Lang, R. A., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.009647 · Cited by 201
Książkiewicz, M., Markiewicz, A., & Żaczek, A. J. (2012) · Pathobiology · doi:10.1159/000337106 · Cited by 190
Boon, E. M. J., Keller, J. J., Wormhoudt, T. A. M., Giardiello, F. M., Offerhaus, G. J. A., van der Neut, R., & Pals, S. T. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601505 · Cited by 190
Wnt-Related Molecules and Signaling Pathway Equilibrium in Hematopoiesis
Malhotra, S., & Kincade, P. W. (2009) · Cell Stem Cell · doi:10.1016/j.stem.2008.12.004 · Cited by 178
Wnt/β-catenin Signaling in Embryonic Stem Cell Self-renewal and Somatic Cell Reprogramming
Miki, T., Yasuda, S.-Y., & Kahn, M. (2011) · Stem Cell Reviews and Reports · doi:10.1007/s12015-011-9275-1 · Cited by 172
Self-citationWnt signaling: relevance to β-cell biology and diabetes
Welters, H. J., & Kulkarni, R. N. (2008) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2008.08.004 · Cited by 167
Stearoyl CoA Desaturase Is Required to Produce Active, Lipid-Modified Wnt Proteins
Rios-Esteves, J., & Resh, M. D. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.08.027 · Cited by 166
CD44 functions in Wnt signaling by regulating LRP6 localization and activation
Schmitt, M., Metzger, M., Gradl, D., Davidson, G., & Orian-Rousseau, V (2015) · Cell Death & Differentiation · doi:10.1038/cdd.2014.156 · Cited by 166
Differential niche and Wnt requirements during acute myeloid leukemia progression.
Lane, S. W., Wang, Y., Celso, C. L., Ragu, C., Bullinger, L., Sykes, S. M., Ferraro, F., Shterental, S., Lin, C. P., Gilliland, D., et al. (2011) · Blood · doi:10.1182/blood-2011-03-345165 · Cited by 162
Wnt/Fz signaling and the cytoskeleton: potential roles in tumorigenesis
Lai, S.-L., Chien, A. J., & Moon, R. T. (2009) · Cell Research · doi:10.1038/cr.2009.41 · Cited by 161
Gang, E. J., Hsieh, Y.-T., Pham, J., Zhao, Y., Nguyen, C., Huantes, S., Park, E., Naing, K., Klemm, L., Swaminathan, S., et al. (2014) · Oncogene · doi:10.1038/onc.2013.169 · Cited by 160
Self-citationBowers, M., Zhang, B., Ho, Y., Agarwal, P., Chen, C., & Bhatia, R. (2015) · Blood · doi:10.1182/blood-2014-06-582924 · Cited by 158
Valencia, A., Román‐Gómez, J., Cervera, J., Such, E., Barragán, E., Bolufer, P., Moscardó, F., Sanz, G. F., & Sanz, M. Á. (2009) · Leukemia · doi:10.1038/leu.2009.86 · Cited by 149
Xiao, J. H., Ghosn, C. R., Hinchman, C., Forbes, C., Wang, J. W., Snider, N., Cordrey, A., Zhao, Y., & Chandraratna, R. A. S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304761200 · Cited by 149
L’Episcopo, F., Tirolo, C., Testa, N., Caniglia, S., Morale, M. C., Deleidi, M., Serapide, M. F., Pluchino, S., & Marchetti, B. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.5259-11.2012 · Cited by 148
Yamazaki, R., Kusunoki, N., Matsuzaki, T., Hashimoto, S., & Kawai, S. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)03535-4 · Cited by 146
Williams, J., Borgo, S., Hasan, I., Castillo, E., Traganos, F., & Rigas, B. (2001) · PubMed · Cited by 137
Inhibition of NF‐ κ B and AP‐1 activation by R‐ and S‐flurbiprofen 1 2
Tegeder, I., Niederberger, E., ISRAR, E., Gühring, H., Brune, K., Euchenhofer, C., Grösch, S., & Geißlinger, G. (2001) · The FASEB Journal · doi:10.1096/fasebj.15.3.595 · Cited by 136
Maier, T. J., Janssen, A., Schmidt, R., Geißlinger, G., & Grösch, S. (2005) · The FASEB Journal · doi:10.1096/fj.04-3274fje · Cited by 136
de Toni, F., Racaud‐Sultan, C., Chicanne, G., Mas, V. M., Cariven, C., Briand‐Mésange, F., Salles, J., Demur, C., Allouche, M., Payrastre, B., et al. (2005) · Oncogene · doi:10.1038/sj.onc.1209346 · Cited by 134
Thrasivoulou, C., Millar, M., & Ahmed, A. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.437913 · Cited by 131
Leukemia stem cells in T-ALL require active Hif1α and Wnt signaling
Giambra, V., Jenkins, C. E., Lam, S. H. L., Hoofd, C., Belmonte, M., Wang, X., Gusscott, S., Gracias, D., & Weng, A. P. (2015) · Blood · doi:10.1182/blood-2014-10-609370 · Cited by 129
A phase I first-in-human study of PRI-724 in patients (pts) with advanced solid tumors.
El-Khoueiry, A. B., Ning, Y., Yang, D., Cole, S., Kahn, M. R., Zoghbi, M., Berg, J., Fujimori, M., Inada, T., Kouji, H., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2013.31.15_suppl.2501 · Cited by 125
Self-citationRepressor roles for TCF-4 and Sfrp1 in Wnt signaling in breast cancer
Shulewitz, M. J., Soloviev, I., Wu, T., Koeppen, H., Polakis, P. G., & Sakanaka, C. (2006) · Oncogene · doi:10.1038/sj.onc.1209470 · Cited by 124
Zhang, Z., Lai, G., & Sirica, A. E. (2004) · Hepatology · doi:10.1002/hep.20143 · Cited by 120
Nath, N., Kashfi, K., Chen, J., & Rigas, B. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2134840100 · Cited by 118
Pre-clinical Specificity and Safety of UC-961, a First-In-Class Monoclonal Antibody Targeting ROR1
Choi, M. Y., Widhopf, G. F., Wu, C. C. N., Cui, B., Lao, F. S., Sadarangani, A., Cavagnaro, J. A., Prussak, C. E., Carson, D. A., Jamieson, C. H. M., et al. (2015) · Clinical Lymphoma Myeloma & Leukemia · doi:10.1016/j.clml.2015.02.010 · Cited by 117
E‐cadherin can limit the transforming properties of activating β‐catenin mutations
Huels, D. J., Ridgway, R. A., Radulescu, S., Leushacke, M., Campbell, A. D., Biswas, S., Leedham, S. J., Serra, S., Chetty, R., Moreaux, G., et al. (2015) · The EMBO Journal · doi:10.15252/embj.201591739 · Cited by 116
Schürch, C. M., Riether, C., Matter, M. S., Tzankov, A., & Ochsenbein, A. F. (2012) · Journal of Clinical Investigation · doi:10.1172/jci45977 · Cited by 110
GLI2 inhibition abrogates human leukemia stem cell dormancy
Sadarangani, A., Pineda, G., Lennon, K. M., Chun, H.-J. E., Shih, A. Y., Schairer, A., Court, A. C., Goff, D. J., Prashad, S., Geron, I., et al. (2015) · Journal of Translational Medicine · doi:10.1186/s12967-015-0453-9 · Cited by 106
Riether, C., Schürch, C. M., Flury, C., Hinterbrandner, M., Drück, L., Huguenin, A.-L., Baerlocher, G. M., Radpour, R., & Ochsenbein, A. F. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aab1740 · Cited by 102
Investigating Wnt signaling: a chemogenomic safari
McMillan, M., & Kahn, M. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03613-5 · Cited by 96
Self-citationFoxO1-dependent induction of acute myeloid leukemia by osteoblasts in mice
Kode, A., Mosialou, I., Manavalan, S. J., Rathinam, C., Friedman, R. A., Teruya‐Feldstein, J., Bhagat, G., Berman, E., & Kousteni, S. (2015) · Leukemia · doi:10.1038/leu.2015.161 · Cited by 95
NO-donating aspirin inhibits intestinal carcinogenesis in Min (APCMin/+) mice
Williams, J. L., Kashfi, K., Ouyang, N., Soldato, P. D., Kopelovich, L., & Rigas, B. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.12.015 · Cited by 90
Chronic versus acute myelogenous leukemia
Jamieson, C. H. M., Weissman, I. L., & Passegue, E. A. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.12.005 · Cited by 89
Wnt inhibition leads to improved chemosensitivity in paediatric acute lymphoblastic leukaemia
Dandekar, S. C., Romanos‐Sirakis, E., Pais, F. M., Bhatla, T., Jones, C. L., Bourgeois, W., Hunger, S. P., Raetz, E. A., Hermiston, M. L., DasGupta, R., et al. (2014) · British Journal of Haematology · doi:10.1111/bjh.13011 · Cited by 82
Kim, J., Kang, Y., Park, G., Kim, M., Park, Y.-O., Kim, H., Leem, S., Chu, I., Lee, J.-S., Jho, E., et al. (2009) · Stem Cells · doi:10.1002/stem.52 · Cited by 77
Kulak, O., Chen, H., Holohan, B., Wu, X., He, H., Borek, D., Otwinowski, Z., Yamaguchi, K., Garofalo, L. A., Ma, Z., et al. (2015) · Molecular and Cellular Biology · doi:10.1128/mcb.00392-15 · Cited by 71
Wnts are dispensable for differentiation and self-renewal of adult murine hematopoietic stem cells
Kabiri, Z., Numata, A., Kawasaki, A., Edison, Tenen, D. G., & Virshup, D. M. (2015) · Blood · doi:10.1182/blood-2014-09-598540 · Cited by 68
Chua, H., Tsuei, D., Lee, P., Jeng, Y., Lu, J., Wu, J., Su, D., Chen, Y., Chien, C., Kao, P., et al. (2015) · Hepatology · doi:10.1002/hep.27996 · Cited by 68
Schwab, M. (2011) · Springer eBooks · doi:10.1007/978-3-642-16483-5_6256 · Cited by 61
Control of Cell Polarity and Asymmetric Division in C. elegans
Sawa, H. (2012) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/b978-0-12-394592-1.00003-x · Cited by 59
Monte, C. D., Carradori, S., Gentili, A., Mollica, A., Trisciuoglio, D., & Supuran, C. T. (2015) · Current Medicinal Chemistry · doi:10.2174/0929867322666150716113501 · Cited by 59
Brudvik, K. W., Paulsen, J. E., Aandahl, E. M., Roald, B., & Taskén, K. (2011) · Molecular Cancer · doi:10.1186/1476-4598-10-149 · Cited by 56
Inhibition of NF‐KB and AP‐1 activation by R‐ and S‐flurbiprofen 1 , 2
Tegeder, I., Niederberger, E., ISRAR, E., Gühring, H., Brune, K., Euchenhofer, C., Grösch, S., & Geißlinger, G. (2001) · The FASEB Journal · doi:10.1096/fasebj.15.1.2 · Cited by 55
CBP/catenin antagonist safely eliminates drug-resistant leukemia-initiating cells
Zhao, Y., Masiello, D., McMillian, M., Nguyen, C., Wu, Y., Melendez, E., Smbatyan, G., Kida, A., He, Y. J., Teo, J.-L., et al. (2015) · Oncogene · doi:10.1038/onc.2015.438 · Cited by 54
Self-citationYang, K. (2003) · Carcinogenesis · doi:10.1093/carcin/24.3.605 · Cited by 48
CD24 is upregulated in inflammatory bowel disease and stimulates cell motility and colony formation
Ahmed, M. A. H., Jackson, D., Seth, R., Robins, A., Lobo, D. N., Tomlinson, I. P. M., & Ilyas, M. (2009) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21134 · Cited by 47
Malhotra, S., & Kincade, P. W. (2008) · Experimental Hematology · doi:10.1016/j.exphem.2008.08.008 · Cited by 46
Rizki, A., & Bissell, M. J. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.06.019 · Cited by 33
Tales From the Crypt: The Expanding Role of Slow Cycling Intestinal Stem Cells
Carlone, D. L., & Breault, D. T. (2012) · Cell stem cell · doi:10.1016/j.stem.2011.12.012 · Cited by 31
Han, J., Gao, B., Jin, X., Xu, Z., Li, Z., Sun, Y., & Song, B. (2012) · Medical Science Monitor · doi:10.12659/msm.883205 · Cited by 29
Ahn, J.-Y., Park, G., Shim, J.-S., et al. (2010) · Experimental & Molecular Medicine · doi:10.3858/emm.2010.42.2.014 · Cited by 25
Hussenet, T., Dembélé, D., Martinet, N., Vignaud, J., & Manoir, S. D. (2010) · Cell Cycle · doi:10.4161/cc.9.2.10421 · Cited by 24
Jansen, S. R., Holman, R., Hedemann, I., Frankes, E., Elzinga, C. R. S., Timens, W., Gosens, R., de Bont, E. S., & Schmidt, M. (2014) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12418 · Cited by 24
Inhibition of NF-kB and AP-1 activation by R- and S-flurbiprofen
Tegeder, I. (2000) · The FASEB Journal · doi:10.1096/fj.00-0130fje · Cited by 18
Unveiling the Secrets to Her Heart
Liu, Y., & Yang, C.-H. (2014) · Neuron · doi:10.1016/j.neuron.2014.06.019 · Cited by 4
Cited by
Nedeljković, M., & Damjanović, A. (2019) · Cells · doi:10.3390/cells8090957 · Cited by 870
Yang, S., Liu, Y., Li, M.-Y., Ng, C. S. H., Yang, S.-L., Wang, S., Zou, C., Dong, Y., Du, J., Long, X., et al. (2017) · Molecular Cancer · doi:10.1186/s12943-017-0700-1 · Cited by 414
Exploring immunotherapy in colorectal cancer
Weng, J., Li, S., Zhu, Z., Liu, Q., Zhang, R., Yang, Y., & Li, X. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01294-4 · Cited by 355
WNT Signaling in Tumors: The Way to Evade Drugs and Immunity
Martin-Orozco, E., Sanchez-Fernandez, A., Ortiz-Parra, I., & Ayala-San Nicolas, M. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02854 · Cited by 286
Ginkgetin: A natural biflavone with versatile pharmacological activities
Adnan, M., Rasul, A., Hussain, G., Shah, M. A., Zahoor, M. K., Anwar, H., Sarfraz, I., Riaz, A., Manzoor, M., Adem, Ş., et al. (2020) · Food and Chemical Toxicology · doi:10.1016/j.fct.2020.111642 · Cited by 102
Metadata
- Authors
- Duchartre, Y., Kim, Y.-M., & Kahn, M.
- Venue
- Critical Reviews in Oncology/Hematology
- Publisher
- Elsevier BV
- Published
- 2016-03
- Volume
- 99
- Pages
- 141-149
- ISSN
- 1040-8428 (ISSN-L)
- OpenAlex
- W2214552500
- Cited by
- 548
- References
- 148
- FWCI
- 10.81
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.